Edward Kim

4.5k total citations · 2 hit papers
105 papers, 2.9k citations indexed

About

Edward Kim is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edward Kim has authored 105 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hepatology, 35 papers in Surgery and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edward Kim's work include Hepatocellular Carcinoma Treatment and Prognosis (59 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Liver Disease Diagnosis and Treatment (19 papers). Edward Kim is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (59 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Liver Disease Diagnosis and Treatment (19 papers). Edward Kim collaborates with scholars based in United States, Canada and Spain. Edward Kim's co-authors include A. Fischman, Rahul Patel, R. Lookstein, F. Nowakowski, Riad Salem, Robert J. Lewandowski, V. Bishay, Siddharth A. Padia, Guy E. Johnson and Ahsun Riaz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Edward Kim

102 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study

2021 289 citations Riad Salem, Edward Kim et al. profile →
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)

2021 165 citations Parissa Tabrizian, Michael Buckstein et al. profile →

Peers

Edward Kim

HEPAT

PRM

EPIDE

SURGE

RNMI

Michael B. Pitton Germany

Emanuela Giampalma Italy

Joana Ferrer Spain

Naoki Matsuo Japan

Bo Hyun Kim South Korea

Kelly Chin United States

Hooman Yarmohammadi United States

Andrea Risaliti Italy

F. W. Schildberg Germany

Sarah Little United Kingdom

Michael B. Pitton Germany

Edward Kim

2.5k ×1.6

HEPAT

1.5k ×1.4

PRM

1.2k ×1.6

EPIDE

1.6k ×2.3

SURGE

476 ×0.9

RNMI

Citations per year, relative to Edward Kim Edward Kim (= 1×) peers Michael B. Pitton

Countries citing papers authored by Edward Kim

Since Specialization

Citations

This map shows the geographic impact of Edward Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Kim more than expected).

Fields of papers citing papers by Edward Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Kim. The network helps show where Edward Kim may publish in the future.

Co-authorship network of co-authors of Edward Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Kim. A scholar is included among the top collaborators of Edward Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Kim. Edward Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salem, Riad, Edward Kim, Robert J. Lewandowski, et al.. (2025). Design and optimization of imageable microspheres for locoregional cancer therapy. Scientific Reports. 15(1). 27487–27487.

Lewandowski, Robert J., Siddharth A. Padia, Edward Kim, et al.. (2025). The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy. Radiology. 316(1). e240333–e240333. 1 indexed citations

Kim, Edward, et al.. (2024). Radiation Segmentectomy for Hepatocellular Carcinoma. Current Oncology. 31(2). 617–628. 6 indexed citations

Stocker, Daniel, Stefanie J. Hectors, Brett Marinelli, et al.. (2024). Prediction of hepatocellular carcinoma response to radiation segmentectomy using an MRI-based machine learning approach. Abdominal Radiology. 50(5). 2000–2011. 4 indexed citations

Aslam, Anum, Victoria Chernyak, Frank H. Miller, et al.. (2024). CT/MRI LI-RADS 2024 Update: Treatment Response Assessment. Radiology. 313(2). e232408–e232408. 16 indexed citations

Bishay, V., Rajesh Patel, Max W. Sung, et al.. (2024). Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 35(5). 722–730.e1. 8 indexed citations

Sher, Alex, et al.. (2023). Update on Locoregional Therapies for Liver Cancer: Radiation Segmentectomy. Current Oncology. 30(12). 10075–10084. 3 indexed citations

Marinelli, Brett, et al.. (2023). Early Prediction of Response of Hepatocellular Carcinoma to Yttrium-90 Radiation Segmentectomy Using a Machine Learning MR Imaging Radiomic Approach. Journal of Vascular and Interventional Radiology. 34(10). 1794–1801.e2. 3 indexed citations

Stocker, Daniel, Michael J. King, Maria El Homsi, et al.. (2023). Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy. European Radiology. 34(1). 475–484. 6 indexed citations

10.

Toskich, Beau B., Edward Kim, Siddharth A. Padia, et al.. (2022). Promoting Surgical Resection through Future Liver Remnant Hypertrophy. Radiographics. 42(7). 2166–2183. 8 indexed citations

11.

Bekki, Yuki, Sara Lewis, Stephen C. Ward, et al.. (2022). Radiological and pathological assessment with EOB-MRI after Y90 radiation lobectomy prior to liver resection for hepatocellular carcinoma. HPB. 24(12). 2185–2192. 3 indexed citations

12.

Buckstein, Michael, Edward Kim, Umut Özbek, et al.. (2022). Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large Hepatocellular Carcinoma: Results From a Prospective Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. 114(2). 221–230. 14 indexed citations

13.

Kennedy, Paul, Sara Lewis, Octavia Bane, et al.. (2021). Early effect of 90Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience. European Radiology. 31(8). 5791–5801. 6 indexed citations

14.

Salem, Riad, Shahzeb Hassan, Robert J. Lewandowski, et al.. (2019). Quality of Life after Radioembolization for Hepatocellular Carcinoma Using a Digital Patient-Reported Outcome Tool. Journal of Vascular and Interventional Radiology. 31(2). 311–314.e1. 8 indexed citations

15.

Knešaurek, Karin, et al.. (2018). Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (90Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with 90Y microspheres. EJNMMI Physics. 5(1). 23–23. 12 indexed citations

16.

Loewenstern, Joshua, C. Stuart Welch, V. Bishay, et al.. (2018). Patient Radiation Exposure in Transradial versus Transfemoral Yttrium-90 Radioembolization: A Retrospective Propensity Score–Matched Analysis. Journal of Vascular and Interventional Radiology. 29(7). 936–942. 10 indexed citations

17.

Biederman, D., J. Titano, N. Tabori, et al.. (2016). Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres. Journal of Vascular and Interventional Radiology. 27(6). 812–821.e2. 43 indexed citations

18.

Phillips, Mark H., et al.. (2016). Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas. International Journal of Radiation Oncology*Biology*Physics. 95(3). 999–1008. 10 indexed citations

19.

Jiang, Manli, F. Nowakowski, Jason Wang, et al.. (2011). Characterization of Extrahepatic Distribution of Tc-99m Macroaggregated Albumin in Hepatic Perfusion Imaging Studies Prior to Yttrium-90 Microsphere Therapy. Cancer Biotherapy and Radiopharmaceuticals. 26(4). 511–518. 9 indexed citations

20.

Kadara, Humam, Carmen Behrens, Ping Yuan, et al.. (2010). A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis. Clinical Cancer Research. 17(6). 1490–1501. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact